These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11440382)

  • 1. Antimicrobial expenditures and usage at four university hospitals. Baden-Württemberg Interuniversity Study Group.
    Kern WV; Rose AD; Hay B; Muche R; Frank U
    Infection; 2001; 29(3):127-37. PubMed ID: 11440382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Otitis media-related antibiotic prescribing patterns, outcomes, and expenditures in a pediatric medicaid population.
    Berman S; Byrns PJ; Bondy J; Smith PJ; Lezotte D
    Pediatrics; 1997 Oct; 100(4):585-92. PubMed ID: 9310510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of an antibiotic restriction policy on hospital expenditures and bacterial susceptibilities: a lesson from a pediatric institution in a developing country.
    Sáez-Llorens X; Castrejón de Wong MM; Castaño E; De Suman O; De Morös D; De Atencio I
    Pediatr Infect Dis J; 2000 Mar; 19(3):200-6. PubMed ID: 10749459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling strategies for reducing pharmaceutical costs in hospital.
    MacIntyre CR; Sindhusake D; Rubin G
    Int J Qual Health Care; 2001 Feb; 13(1):63-9. PubMed ID: 11330446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case study of the effects of office-based generic drug sampling on antibiotic drug costs and first-line antibiotic prescribing ratios.
    Conklin MH; Culley EJ; O'Donnell J
    J Manag Care Pharm; 2009; 15(1):55-61. PubMed ID: 19125550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the use of health resources by Spanish and immigrant HIV-infected patients.
    Velasco M; Castilla V; Guijarro C; Moreno L; Barba R; Losa JE
    Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):458-62. PubMed ID: 22377495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the unit costs of public hospitals and primary healthcare centers.
    Younis MZ; Jaber S; Mawson AR; Hartmann M
    Int J Health Plann Manage; 2013; 28(4):320-32. PubMed ID: 23125096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surveillance and the costs related to the prescription of antimicrobials in a pediatric hospital].
    Navarrete-Navarro S; Avila-Figueroa C; Medina-Cuevas F; Santos-Preciado JI
    Gac Med Mex; 1999; 135(4):383-9. PubMed ID: 10491893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Quality Assessment of a Collaborative Model of a Pediatric Antimicrobial Stewardship Program.
    Nguyen-Ha PT; Howrie D; Crowley K; Vetterly CG; McGhee W; Berry D; Ferguson E; Polischuk E; Brooks MM; Goff J; Stillwell T; Darville T; Thompson AE; Levin JE; Michaels MG; Green M
    Pediatrics; 2016 May; 137(5):. PubMed ID: 27244775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating average expenditures per case in Kaunas University of Medicine Hospital.
    Kalibatas V; Petrauskiene J; Pundzius J
    Medicina (Kaunas); 2004; 40(10):1004-13. PubMed ID: 15516826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antibiotic order form guiding rational use of expensive drugs on cost containment.
    Sirinavin S; Suvanakoot P; Sathapatayavongs B; Malatham K
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):636-42. PubMed ID: 10437971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug utilization, rationality, and cost analysis of antimicrobial medicines in a tertiary care teaching hospital of Northern India: A prospective, observational study.
    Bimba HV; Roy V; Batta A; Daga MK
    Indian J Pharmacol; 2020; 52(3):179-188. PubMed ID: 32874000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benchmark analysis of strategies hospitals use to control antimicrobial expenditures.
    Rifenburg RP; Paladino JA; Hanson SC; Tuttle JA; Schentag JJ
    Am J Health Syst Pharm; 1996 Sep; 53(17):2054-62. PubMed ID: 8870892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of benchmarking techniques to justify the evolution of antibiotic management programs in healthcare systems.
    Schentag JJ; Paladino JA; Birmingham MC; Zimmer G; Carr JR; Hanson SC
    J Pharm Technol; 1995; 11(5):203-10. PubMed ID: 10151512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost of antimicrobial treatment for nosocomial infections based on a French prevalence survey.
    Astagneau P; Fleury L; Leroy S; Lucet JC; Golliot F; Régnier B; Brücker G
    J Hosp Infect; 1999 Aug; 42(4):303-12. PubMed ID: 10467544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The costs of childhood epilepsy in Italy: comparative findings from three health care settings.
    Guerrini R; Battini R; Ferrari AR; Veggiotti P; Besana D; Gobbi G; Pezzani M; Berta E; Tetto A; Beghi E; Monticelli ML; Tediosi F; Garattini L; Russo S; Rasmini P; Amadi A; Quarti P; Fabrizzi R;
    Epilepsia; 2001 May; 42(5):641-6. PubMed ID: 11380572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in antibiotic prescribing in three university hospitals in the Baltic region revealed by a simple protocol for quality assessment of therapeutic indications.
    Dumpis U; Gulbinovic J; Struwe J; Lagergren A; Griskevicius L; Bergman U
    Int J Clin Pharmacol Ther; 2007 Oct; 45(10):568-76. PubMed ID: 17966843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost of antimicrobial therapy across US children's hospitals.
    Ross RK; Hersh AL; Kronman MP; Newland JG; Gerber JS
    Infect Control Hosp Epidemiol; 2015 Oct; 36(10):1242-4. PubMed ID: 26166408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989.
    Coleman RW; Rodondi LC; Kaubisch S; Granzella NB; O'Hanley PD
    Am J Med; 1991 Apr; 90(4):439-44. PubMed ID: 1901446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Direct costs and hospital morbimortality impact from preventable adverse drug events].
    Pinzón JF; Maldonado C; Díaz JA; Segura O
    Biomedica; 2011; 31(3):307-15. PubMed ID: 22674307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.